Search
Login
IDR Home
→
Article
→
Department of Pharmaceutical Engineering
→
Search
JavaScript is disabled for your browser. Some features of this site may not work without it.
Search
Filters
Use filters to refine the search results.
Current Filters:
Title
Author
Subject
Date issued
Has File(s)
Contains
Equals
ID
Not Contains
Not Equals
Not ID
New Filters:
Title
Author
Subject
Date issued
Has File(s)
Contains
Equals
ID
Not Contains
Not Equals
Not ID
Showing 8 out of a total of 8 results for collection: Department of Pharmaceutical Engineering.
(0.009 seconds)
Now showing items 1-8 of 8
1
Sort Options:
Relevance
Title Asc
Title Desc
Issue Date Asc
Issue Date Desc
Results Per Page:
5
10
20
40
60
80
100
Nanovaccine for immunotherapy and reduced hepatitis-B virus in humanized model
Dewangan, Hitesh Kumar
;
Pandey, Tarun
;
Singh, Sanjay
(
Taylor and Francis Ltd.
,
2017-11-20
)
Rational design and in-vivo estimation of Ivabradine Hydrochloride loaded nanoparticles for management of stable angina
Sharma, Vipin
;
Dewangan, Hitesh Kumar
;
Maurya, Lakshmi
;
Vats, Kanchan
;
Verma, Himanshu
;
Singh, Sanjay
(
Editions de Sante
,
2019-11-20
)
Antiulcer activity of the most active sub-fraction of methanolic leaf extract of Buchanania Lanzan Spreng
Rai, Uddipak
;
Pattnaik, Ashok Kumar
;
Singh, Sanjay
(
Innovare Academics Sciences Pvt. Ltd
,
2016-07-22
)
Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design, In Vitro and In Vivo Studies
Mishra, Amit
;
Vuddanda, Parameswara Rao
;
Singh, Sanjay
(
Hindawi Publishing Corporation
,
2014-02-19
)
Low expression of TMPRSS2–a SARS-CoV-2 internalization protease–associates with basal subtype of head and neck squamous cell carcinoma
Tiwari, Jayesh
;
Tripathi, Nancy
;
Srivastava, Ravi Shanker
;
Kumar, Sujeet
;
Singh, Sanjay
;
Jain, Shreyans
;
Khattri, Arun
(
Neoplasia Press, Inc.
,
2022-08
)
Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer
Kumar, Dulla Naveen
;
Chaudhuri, Aiswarya
;
Dehari, Deepa
;
Shekher, Anusmita
;
Gupta, Subash C.
;
Majumdar, Shreyasi
;
Krishnamurthy, Sairam
;
Singh, Sanjay
;
Kumar, Dinesh
;
Agrawal, Ashish Kumar
(
MDPI
,
2022-08
)
Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Chaudhuri, Aiswarya
;
Kumar, Dulla Naveen
;
Dehari, Deepa
;
Singh, Sanjay
;
Kumar, Pradeep
;
Bolla, Pradeep Kumar
;
Kumar, Dinesh
;
Agrawal, Ashish Kumar
(
MDPI
,
2022-05
)
Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application
Kumar, Dulla Naveen
;
Chaudhuri, Aiswarya
;
Aqil, Farrukh
;
Dehari, Deepa
;
Munagala, Radha
;
Singh, Sanjay
;
Gupta, Ramesh C.
;
Agrawal, Ashish Kumar
(
MDPI
,
2022-03
)
Now showing items 1-8 of 8
1
Sort Options:
Relevance
Title Asc
Title Desc
Issue Date Asc
Issue Date Desc
Results Per Page:
5
10
20
40
60
80
100
Browse
All of IDR
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
My Account
Login
Register
Discover
Author
Singh, Sanjay (8)
Agrawal, Ashish Kumar (3)
Chaudhuri, Aiswarya (3)
Dehari, Deepa (3)
Kumar, Dulla Naveen (3)
Dewangan, Hitesh Kumar (2)
Kumar, Dinesh (2)
Aqil, Farrukh (1)
Bolla, Pradeep Kumar (1)
Gupta, Ramesh C. (1)
... View More
Subject
5-fluorouracil (1)
8 [4 (1 aminocyclobutyl)phenyl] 9 phenyl 1,2,4 triazolo[3,4 f][1,6]naphthyridin 3(2h) one; abiraterone acetate; alpelisib; androgen receptor; anthracycline derivative; antibody drug conjugate; antineoplastic antimetabolite; apitolisib; asparaginase macrogol; atezolizumab; avelumab; azacitidine; bendamustine; bevacizumab; bicalutamide; bimiralisib; binimetinib; buparlisib; capecitabine; capivasertib; carbon nanotube; carboplatin; cetuximab; cisplatin; citral; cobimetinib; curcumin; cyclophosphamide; cytarabine; cytotoxic T lymphocyte antigen 4; dasatinib; daunorubicin; decitabine; dendrimer; diallyl disulfide; docetaxel; doxorubicin; durvalumab; edelfosine; enzalutamide; epidermal growth factor receptor; epirubicin; eribulin; erlotinib; etoposide; everolimus; floxuridine; fluoropyrimidine derivative; fluorouracil; galunisertib; gambogic acid; gamma secretase inhibitor; gedatolisib; gefitinib; gemcitabine; halofuginone; honokiol; idarubicin; immune checkpoint inhibitor; ipatasertib; irinotecan; ixabepilone; lapachol; liposome; lycopene; metal nanoparticle; methotrexate; mitomycin; mitoxantrone; mk 0752; n (6,7 dihydro 6 oxo 5h dibenz[b,d]azepin 7 yl) 2,2 dimethyl n' (2,2,3,3,3 pentafluoropropyl)propanediamide; nanocarrier; nanoparticle; niclosamide; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 1; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor; niraparib; nirogacestat; olaparib; olinvacimab; omega 3 fatty acid; orteronel; paclitaxel; palbociclib; panitumumab; panobinostat; pembrolizumab; piperine; platinum complex; polymeric micelle; prednisone; programmed death 1 ligand 1; protein tyrosine kinase; quercetin; resveratrol; ridaforolimus; rucaparib; sacituzumab govitecan; saracatinib; selumetinib; silver nanoparticle; sirolimus; small interfering RNA; solid lipid nanoparticle; somatomedin C receptor; talazoparib; taselisib; taxane derivative; teniposide; tetrahydrolipstatin; thymoquinone; unclassified drug; valrubicin; vandetanib; veliparib; vincristine; vinorelbine tartrate; vistusertib; vorinostat (1)
adjuvant therapy; Akt signaling; basal like breast cancer; brain metastasis; breast cancer; breast cancer recurrence; cancer incidence; cancer prognosis; cancer regression; cancer resistance; colon cancer; disease free survival; distant metastasis; drug bioavailability; drug delivery system; drug formulation; drug penetration; drug solubility; encapsulation; epithelial mesenchymal transition; gene expression profiling; hedgehog signaling; human; lung cancer; lung metastasis; lymphocytopenia; metastatic breast cancer; molecularly targeted therapy; monotherapy; nanoemulsion; nanomedicine; non-canonical Wnt signaling; nonhuman; Notch signaling; ovary cancer; overall survival; partial mastectomy; personalized medicine; progression free survival; Review; self emulsifying drug delivery system; TGF beta signaling; triple negative breast cancer; tumor invasion; tumor microenvironment; visceral metastasis (1)
Anacardiaceae (1)
angiotensin converting enzyme 2 (1)
Anti-anginal activity (1)
antineoplastic agent (1)
Antiulcer (1)
Article; cancer patient; cohort analysis; comparative study; controlled study; coronavirus disease 2019; gene expression; genetic susceptibility; head and neck squamous cell carcinoma; human; Human papillomavirus type 1; major clinical study; mesenchymal stem cell; nonhuman; protein expression; RNA sequence; treatment response (1)
biogenesis; breast cancer; cancer diagnosis; chromatography; clinical trial (topic); density gradient centrifugation; diagnostic test; differential ultracentrifugation; disease management; disease marker; drug delivery system; drug loading; electroporation; exosome; freeze thawing; gene overexpression; genetic transfection; human; immunoaffinity chromatography; intermethod comparison; isolation procedure; magnetism; nonhuman; pH; precipitation; Review; surface charge; ultracentrifugation; ultrafiltration; ultrasound (1)
... View More
Date Issued
2022 (4)
2014 (1)
2016 (1)
2017 (1)
2019 (1)
Has File(s)
Yes (8)